IMMUNE-MEDIATED ADVERSE REACTIONS
See full prescribing information for complete boxed warning
- TRADE NAME: Yervoy (Bristol-Myers Squibb)
- INDICATIONS: Melanoma
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Biologic, CTLA-4-blocking monoclonal antibody, Immune checkpoint inhibitor (incl. programmed death receptor-1 (PD-1) inhibitor), Monoclonal antibody
- HALF-LIFE: 15 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to view the rest of this drug profile.
Page last updated 03/26/2025
